{"effective_time":"20120509","id":"a3bd583c-24d7-411a-ac85-03319cd70809","openfda":{},"package_label_principal_display_panel":["PRINCIPAL DISPLAY PANEL - 2% Cartridge Carton HENRY SCHEIN ® NDC 0404-6740-05 MEPIVACAINE HCl 2% and LEVONORDEFRIN 1:20,000 INJECTION (MEPIVACAINE HCl AND LEVONORDEFRIN INJECTION, USP) 50 Cartridges 1.7 mL Minimum Rx Only PRINCIPAL DISPLAY PANEL - 50 2% Cartridge Carton","PRINCIPAL DISPLAY PANEL - 3% Cartridge Carton HENRY SCHEIN ® NDC 0404-6730-05 MEPIVACAINE HCl 3% INJECTION without VASOCONSTRICTOR (MEPIVACAINE HCl INJECTION, USP) 50 Cartridges 1.7 mL Minimum Rx Only PRINCIPAL DISPLAY PANEL - 50 3% Cartridge Carton"],"set_id":"e6a10603-9214-4380-a499-2779af36387b","spl_product_data_elements":["Mepivacaine Hydrochloride with Levonordefrin Mepivacaine Hydrochloride and Levonordefrin Mepivacaine Hydrochloride Mepivacaine Levonordefrin Levonordefrin Sodium Chloride Potassium metabisulfite Edetate disodium Sodium Hydroxide Hydrochloric Acid Water Mepivacaine Hydrochloride Mepivacaine Hydrochloride Mepivacaine Hydrochloride Mepivacaine Sodium Chloride Sodium Hydroxide Water"],"version":"1"}